Arylsulfonamide agonists of the human beta 3 adrenergic receptor for the treatment of obesity.

被引：0

作者：

Weber, AE ^{[1
]}

Mathvink, RJ ^{[1
]}

Hutchins, JE ^{[1
]}

Perkins, LM ^{[1
]}

Parmee, ER ^{[1
]}

Ok, HO ^{[1
]}

Candelore, MR ^{[1
]}

Vicario, PP ^{[1
]}

Cascieri, MA ^{[1
]}

Strader, CD ^{[1
]}

Hom, GJ ^{[1
]}

Forrest, MJ ^{[1
]}

MacIntyre, DE ^{[1
]}

Alvaro, RF ^{[1
]}

Kao, J ^{[1
]}

Wyvratt, MJ ^{[1
]}

Fisher, MH ^{[1
]}

机构：

[1] MERCK & CO INC,MERCK SHARP & DOHME RES LABS,RAHWAY,NJ 07065

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1997年 / 213卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页码：168 / MEDI

页数：1

共 50 条

[31] Substituted oxazole benzenesulfonamides as potent human β3 adrenergic receptor agonists
Ok, HO
Reigle, LB
Candelore, MR
Cascieri, MA
Colwell, LF
Deng, L
Feeney, WP
Forrest, MJ
Hom, GJ
MacIntyre, DE
Strader, CD
Tota, L
Wang, P
Wyvratt, MJ
Fisher, MH
Weber, AE
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1188 - U1188
[32] Potent, selective agonists of the human β3-adrenergic receptor.
Solvibile, WR
Ashwell, MA
Molinari, AJ
Han, S
Largis, E
Mulvey, R
Tillet, J
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U645 - U645
[33] Potent benzimidazolone based human β3-adrenergic receptor agonists
Finley, Don R.
Bell, Michael G.
Borel, Anthony G.
Bloomquist, William E.
Cohen, Marlene L.
Heiman, Mark. L.
Kriauciunas, Aidas
Matthews, Donald P.
Miles, Tania
Neel, David A.
Rito, Christopher J.
Sall, Daniel J.
Shuker, Anthony J.
Stephens, Thomas W.
Tinsley, Frank C.
Winter, Mark A.
Jesudason, Cynthia D.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (21) : 5691 - 5694
[34] The use of β3-adrenergic receptor agonists in the treatment of heart failure
Rasmussen, Helge H.
Figtree, Gemma A.
Krum, Henry
Bundgaard, Henning
CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (09) : 955 - 962
[35] Synthesis and biological evaluation of novel, selective 5-HT2C receptor agonists for the treatment of obesity.
Robichaud, AJ
Chen, WT
McClung, C
Clark, D
Deng, W
Brondyke-Calvello, E
Mitchell, IS
Lee, TY
Rajagopalan, P
Fitzgerald, LW
Conklin, DS
McElroy, JF
Rohrbach, KW
Miller, KJ
Largent, BL
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U19 - U19
[36] Polymorphic variants in the beta-3-adrenergic receptor gene and TNF-α genes do not influence traits related to Type 2 diabetes and obesity.
Johnson, S
Seibert, M
Thorne, N
Andersen, RE
Walston, J
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (09) : S21 - S21
[37] Novel β3 adrenergic receptor agonists.
Yanai, M
Takahashi, T
Kawamura, K
Ueno, M
Hiramoto, S
Katsuyama, K
Fuchizawa, S
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U590 - U590
[38] MOLECULAR CHARACTERIZATION OF THE HUMAN BETA-3-ADRENERGIC RECEPTOR
EMORINE, LJ
MARULLO, S
BRIENDSUTREN, MM
PATEY, G
TATE, K
DELAVIERKLUTCHKO, C
STROSBERG, AD
SCIENCE, 1989, 245 (4922) : 1118 - 1121
[39] The beta-3-adrenergic receptor in anxiety disorders and their treatment
Stemmelin, J.
Cohen, C.
Griebel, G.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S195 - S196
[40] ANTIBODIES FOR THE IMMUNOCHEMISTRY OF THE HUMAN BETA-3-ADRENERGIC RECEPTOR
GUILLAUME, JL
PETITJEAN, F
HAASEMANN, M
BIANCHI, C
ESHDAT, Y
STROSBERG, AD
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 224 (02): : 761 - 770

← 1 2 3 4 5 →